Tag: FAS Russia

Federal Antimonopoly Service (the FAS Russia) is an authorized federal executive body, which is carrying out its functions with regard to the approval of the regulatory legal acts and control over compliance with the antimonopoly legislation, legislation in the field of natural monopolies’ activity, in the field of state regulation of prices (tariffs) for the goods (services), advertising, foreign investments in the business entities of strategic importance for the Russian national defence and state security, control in the field of state defence order, purchases of goods, works and services for the state and municipal needs and procurement of goods, works and services by certain legal entities, as well as with regard to the approval of closed methods for selection of suppliers (contractors, performers).

FAS will inspect large pharmaceutical companies once in 5 years

The Russian Government signed a Decree that approved the criteria for assigning specific risk categories to legal entities and individual entrepreneurs.

SPICs should involve the transfer of unique technologies

fas russia
“Special Investment Contract cannot provide guarantees for the implementation of unfair activities,” said Timofey Nizhegorodtsev, the Head of the Department for Control over Social Sphere and Trade of FAS of Russia.

FAS of Russia identified unjustified 35% overpricing of Tyverb

FAS Russia
In April 2017, the FAS Russia initiated a case on the grounds that Novartis Pharma had violated Clause 1 of Part 1 of Article 10 of the Law on Protection of Competition

FAS will support Russian manufacturers in the registration of prices

The head of Federal Antimonopoly Service of Russia Igor Artemyev met with the executives of Pharmstandard PJSC and BIOCAD CJSC

FAS Russia reports on the most frequent violations in healthcare sector

The Federal Antimonopoly Service of Russia participates in the reform of control and oversight activities

Russian Court restricts the authority of FAS for interchangeability of drugs

Today, the procurement of drugs is regulated by the Federal Law FZ-44, under which the state customer has the right to specify INN of the drug and other "product characteristics" in the description of the lot

Russia and BRICS countries will oppose the transnational pharmaceutical companies

Russia, together with other BRICS countries, will take measures against transnational drug manufacturers involved in bribing the doctors and selling expired medicines

FAS of Russia advocates the “third wheel” rule transformation

Igor Artemyev, the Head of the Federal Antimonopoly Service of Russia, spoke about his agency's position on the current use of “third wheel” rule in public procurement of drugs

Russia may authorize compulsory licensing of medicinal products this year

The procedure for compulsory licensing of drugs may be introduced in Russia as early as this year, said Igor Artemyev, the Head of the Federal Antimonopoly Service.

“Percentage” preferences will provide incentives to localize manufacturing

Rachik Petrosyan, the Deputy Head of the Russian Antimonopoly Service (FAS), said that his agency views the presence of foreign suppliers as a tremendous benefit for the Russian market

Reduction of prices on VED in Russia will save more than 5 billion rubles

Igor Artemyev, the Head of the Federal Antimonopoly Service, informed Dmitry Medvedev, the Chairman of the Government of the Russian Federation, on the results of measures taken to reduce the prices of vital and essential drugs

B. Brown Medical is suspected to be involved in cartel agreement

fas russia
The Federal Antimonopoly Service (FAS) of Russia is suspecting the Russian subsidiary of B. Braun Medical, a German company, to be involved in one of the largest cartel agreements in the sale of medicines

Rospatent does not support FAS proposals and takes side of drug patent holders

Russian Federal Service for Intellectual Property (Rospatent) considers as redundant and dangerous for the industry the amendments to Article 1360 of the Civil Code proposed by the Russian Federal Antimonopoly Service

Medicines with dominant position in the Russian market

fas russia
The Russian Federal Antimonopoly Service (FAS) named 16 medicinal products holding more than 50% of their commercial markets. This information is based on the analysis of competition in the commercial...

Russian FAS proposed to equalize VED prices within the Customs Union

Manufacturers of vital and essential drugs (VED) may be obliged to lower their prices to the level of prices for the same drugs in the countries of the Customs Union. Such proposal is promoted by the ...

FAS Russia worked up a law for anti-competitive agreements

On April 2, 2017, the Council of the Federation unanimously adopted a bill that establishes the differentiation of punishments for anti-competitive agreements and concerted actions based on the degree...